Processa Pharmaceuticals Inc (PCSA)
1.73
-0.08
(-4.42%)
USD |
NASDAQ |
Jul 05, 16:00
1.73
0.00 (0.00%)
After-Hours: 18:28
Processa Pharmaceuticals Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.0028M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.4755M |
| June 30, 2018 | -0.496M |
| March 31, 2018 | -0.0018M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.005M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | -0.025M |
| June 30, 2016 | 0.015M |
| March 31, 2016 | 0.027M |
| December 31, 2015 | 0.0416M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -0.0014M |
| December 31, 2014 | -0.0226M |
| September 30, 2014 | -0.0099M |
| June 30, 2014 | -0.002M |
| March 31, 2014 | -0.0104M |
| December 31, 2013 | -0.00 |
| September 30, 2013 | -0.0203M |
| June 30, 2013 | -0.0011M |
| March 31, 2013 | -0.0063M |
| December 31, 2012 | -0.0144M |
| September 30, 2012 | -0.2443M |
| June 30, 2012 | -0.0757M |
| March 31, 2012 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.0028M
Minimum
Sep 2023
--
Maximum
Sep 2022
-0.0007M
Average
--
Median
Sep 2022
Cash from Investing (Quarterly) Benchmarks
| Geovax Labs Inc | -- |
| Biomea Fusion Inc | -0.035M |
| DIH Holding US Inc | -- |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.049M |
| Cash from Financing (Quarterly) | 6.263M |
| Free Cash Flow | -7.998M |
| Free Cash Flow Per Share (Quarterly) | -0.8307 |
| Free Cash Flow Yield | -281.4% |